Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 USD | +2.25% | -0.44% | -36.24% |
Mar. 14 | Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.24% | 81.38M | |
+21.31% | 46.81B | |
-0.92% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.30% | 26.06B | |
-19.35% | 19.13B | |
+32.34% | 12.39B | |
+0.16% | 12.08B | |
+0.28% | 11.96B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Protalix BioTherapeutics : HC Wainwright Adjusts Price Target on Protalix BioTherapeutics to $7 From $11, Maintains Buy Rating